Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CXCR4 reduces aldosterone synthesis via regulating CYP11B2 expression.

Genes & diseases·2026
Same author

Variance Estimation for Weighted Average Treatment Effects.

Statistics in biosciences·2026
Same author

68Ga-Pentixafor PET/CT for diagnosing surgically curable primary aldosteronism concurrent with autonomous cortisol secretion.

Journal of hypertension·2026
Same author

The diagnostic value of 68Ga-pentixafor PET/CT in differentiating adrenal aldosterone-producing adenomas from non-functional adenomas.

Endocrine-related cancer·2026
Same author

The perspective of manual therapy as a fascia-directed biomechanical intervention in myofascial pain syndrome.

Frontiers in medicine·2026
Same author

Estimation and inference of the win ratio for two hierarchical endpoints subject to censoring and missing data.

Journal of biopharmaceutical statistics·2026

Related Experiment Video

Updated: Apr 30, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.0K

Evaluating marker-guided treatment selection strategies.

Roland A Matsouaka1, Junlong Li2, Tianxi Cai2

  • 1Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA.

Biometrics
|May 1, 2014
PubMed
Summary
This summary is machine-generated.

This study introduces a robust two-step method to create and evaluate individualized treatment rules (ITRs) using multiple patient markers. This approach improves treatment selection and quantifies the value of new markers for better healthcare outcomes.

Keywords:
Biomarker‐analysis designCounterfactual outcomePersonalized medicinePerturbation‐resamplingPredictive biomarkersSubgroup analysis

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.0K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.2K

Related Experiment Videos

Last Updated: Apr 30, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.0K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.0K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.2K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Precision Medicine

Background:

  • Individualized treatment rules (ITRs) can enhance healthcare efficiency by tailoring treatments using patient-specific data.
  • Current methods for evaluating ITRs often rely on single markers or are prone to bias from model misspecification.

Purpose of the Study:

  • To propose a robust two-step method for deriving and evaluating ITRs in a general setting with multiple markers.
  • To develop procedures for comparing ITRs and quantifying the incremental value of new markers for treatment selection.

Main Methods:

  • A two-step robust method is proposed, incorporating a calibration layer to mitigate model misspecification.
  • Non-parametric assessment of ITR value and resampling procedures for confidence intervals are utilized.
  • The method is validated through extensive simulations and applied to an HIV-1 clinical trial dataset.

Main Results:

  • The proposed method effectively derives and evaluates ITRs using multiple markers.
  • Procedures for comparing ITRs and quantifying the incremental value of markers are demonstrated.
  • Valid confidence intervals for value functions and incremental marker values are obtained.

Conclusions:

  • The developed two-step robust method provides a valid approach for deriving and evaluating ITRs with multiple markers.
  • This methodology enhances treatment selection and aids in assessing the value of incorporating new biomarkers in clinical practice.
  • The findings are applicable to improving patient outcomes in various clinical settings, including HIV treatment.